AUSTIN, Texas-Alafair Biosciences Inc., an emerging medical device company, announced today that it received 510(k) clearance from the FDA to market and sell its tendon product, VersaWrap™ Tendon Protector, in the US. VersaWrap™ Tendon Protector is an ultrathin, sutureless, bioresorbable… Read More
Congratulations to Dr. John Sheets who has been appointed as the new director of FDA’s premarket review office for devices. Sheets is a UF alumnus and a former UF BME external advisory board member. Prior to joining the FDA, Sheets… Read More
The Celebration of Biotechnology is an outdoor event showcasing the life sciences community in the region and throughout Florida. Now, in its 13th year and hosted by RTI Surgical and UF Sid Martin Biotech Institute, the Celebration continues to attract… Read More
On November 16, the department of Biomedical Engineering at UF hosted the 4th Annual Pruitt Research Day. Pruitt Research Day is designed to showcase the quality of student research projects conducted during the academic year, as well as to inspire… Read More
The J. Crayton Pruitt Family Department of Biomedical Engineering is proud to announce our newest industry partner: Sigma Aldrich Corporation. Sigma-Aldrich Corporation is an American life science and high technology company with over 9,600 employees and operations in 40 countries.… Read More
Please join us for a special seminar presented by Dr. Brian Thomas of Stryker Sustainability Solutions! Stryker is the leading provider of reprocessing and remanufacturing services for medical devices as well as comprehensive recycling and redistribution initiatives. They are also… Read More
The Tim Brahm Endowed Term Professorship in Biomedical Engineering was founded in 2015 to bolster a collaborative research partnership between the University of Florida J. Crayton Pruitt Family Department of Biomedical Engineering and the biotechnology company, BioD. BioD is… Read More
SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc. CEO Karen Zaderej on Helping Our Injured Military Members – First in a Series of Three Interviews Interview Airs June 16, 2015, Host Geraldo Rivera, 10:52 AM ET | 9:52 AM… Read More
Study demonstrates technical feasibility and promising ability to restore erectile function and reduce incontinence. ALACHUA, FL – June 9, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral nerve repair market, announced results from… Read More
Study to compare Company’s proprietary processed human nerve allograft to hollow tubes for bridging gaps in peripheral nerve tissue. ALACHUA, FL, May 4, 2015 – AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company dedicated to the $1.6 billion peripheral… Read More